Brenda Banwell, MD, Chief, Division of Neurology, Professor of Neurology, Perelman School of Medicine at the University of Pennsylvania, said that there are 3 areas of treatment associated with pediatric multiple sclerosis (MS). The first is the treatment of the acute attack. The acute attack, or relapse, is treated the same in both pediatric and adult cases with corticosteroids or immunoglobulin. The second treatment area is chronic multiple sclerosis where first-line therapies are utilized like Interferon beta 1a, Interferon beta 1b, and glatiramer acetate. Finally, there is escalation therapy, which can be treated with natalizumab. International consensus guidelines and shared care models are used by clinicians to treat patients because there are no clinical trials for the treatment of pediatric MS today.
Share this Video
Related Videos In Paediatric Neurology
Christopher Glisson, AAN 2019 – Updates in pediatric neuro-ophthalmology
Christopher Glisson (Mercy Health Hauenstein Neurosciences, Michigan, USA) kindly took the time to talk us on the topic of his update session at AAN on pediatric neuro-ophthalmology. Questions What are the particular challenges of paediatric as opposed to adult neuro-ophthalmology? (0:04) What are the most commonly seen optic neuropathies in childhood? (0:47) What is […]
John Bodensteiner, AAN 2018 – Expert perspective on Duchenne muscular dystrophy
John Bodensteiner (Consultant, Child and Adolescent Neurology), our Paediatric Neurology Section Editor for US Neurology, shares his expert perspective on Duchenne muscular dystrophy. Questions 1. What do you consider the most promising current and emerging treatment options for Duchenne Muscular Dystrophy (DMD)? (0:11) 2. Could you tell us a little about the CINRG Duchenne Natural […]
John Bodensteiner, AAN 2018 – Advances in molecular and genetic diagnosis in paediatric neurology
John Bodensteiner (Consultant, Child and Adolescent Neurology), our Paediatric Neurology Section Editor for US Neurology, discusses the impact recent advances in molecular and genetic diagnosis have had in paediatric neurology on conditions such as Duchenne muscular dystrophy and spinal muscular atrophy. Speaker disclosure: John Bodensteiner has nothing to disclose in relation to this video interview. […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!